• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

cGAS/STING通路——胃癌的一个新的潜在生物治疗靶点?

The cGAS/STING Pathway-A New Potential Biotherapeutic Target for Gastric Cancer?

作者信息

Tian Mengxiang, Zhang Shuai, Tan Fengbo

机构信息

Department of General Surgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410017, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410017, China.

出版信息

J Pers Med. 2024 Jul 9;14(7):736. doi: 10.3390/jpm14070736.

DOI:10.3390/jpm14070736
PMID:39063990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11277918/
Abstract

Gastric cancer ranks among the top five deadliest tumors worldwide, both in terms of prevalence and mortality rates. Despite mainstream treatments, the efficacy in treating gastric cancer remains suboptimal, underscoring the urgency for novel therapeutic approaches. The elucidation of tumor immunosuppressive microenvironments has shifted focus towards cancer biotherapeutics, which leverage the patient's immune system or biologics to target tumor cells. Biotherapy has emerged as a promising alternative for tumors resistant to traditional chemotherapy, radiation, and immunotherapy. Central to this paradigm is the cGAS-STING pathway, a pivotal component of the innate immune system. This pathway recognizes aberrant DNA, such as that from viral infections or tumor cells, and triggers an immune response, thereby reshaping the immunosuppressive tumor microenvironment into an immune-stimulating milieu. In the context of gastric cancer, harnessing the cGAS-STING pathway holds significant potential for biotherapeutic interventions. This review provides a comprehensive overview of the latest research on cGAS-STING in gastric cancer, including insights from clinical trials involving STING agonists. Furthermore, it assesses the prospects of targeting the cGAS-STING pathway as a novel biotherapeutic strategy for gastric cancer.

摘要

无论从发病率还是死亡率来看,胃癌都是全球最致命的五大肿瘤之一。尽管有主流治疗方法,但胃癌的治疗效果仍不尽人意,凸显了新型治疗方法的紧迫性。肿瘤免疫抑制微环境的阐明使人们将重点转向癌症生物疗法,即利用患者的免疫系统或生物制剂来靶向肿瘤细胞。生物疗法已成为对传统化疗、放疗和免疫疗法耐药的肿瘤的一种有前景的替代方法。这一模式的核心是cGAS-STING通路,它是固有免疫系统的关键组成部分。该通路识别异常DNA,如来自病毒感染或肿瘤细胞的DNA,并触发免疫反应,从而将免疫抑制性肿瘤微环境重塑为免疫刺激性环境。在胃癌的背景下,利用cGAS-STING通路进行生物治疗干预具有巨大潜力。本综述全面概述了胃癌中cGAS-STING的最新研究,包括涉及STING激动剂的临床试验的见解。此外,它还评估了靶向cGAS-STING通路作为胃癌新型生物治疗策略的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e324/11277918/45e697c68800/jpm-14-00736-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e324/11277918/0b497f1b9b4b/jpm-14-00736-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e324/11277918/45e697c68800/jpm-14-00736-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e324/11277918/0b497f1b9b4b/jpm-14-00736-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e324/11277918/45e697c68800/jpm-14-00736-g002.jpg

相似文献

1
The cGAS/STING Pathway-A New Potential Biotherapeutic Target for Gastric Cancer?cGAS/STING通路——胃癌的一个新的潜在生物治疗靶点?
J Pers Med. 2024 Jul 9;14(7):736. doi: 10.3390/jpm14070736.
2
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions.利用cGAS-STING通路增强放射治疗:当前方法与未来方向
Front Pharmacol. 2024 Apr 10;15:1383000. doi: 10.3389/fphar.2024.1383000. eCollection 2024.
3
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.纳米材料介导的cGAS-STING信号通路调节以增强癌症免疫治疗
Acta Biomater. 2024 Mar 1;176:51-76. doi: 10.1016/j.actbio.2024.01.008. Epub 2024 Jan 17.
4
Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.通过联合 cGAS-STING 通路策略靶向重塑肿瘤微环境来增强免疫疗法的效果。
Front Immunol. 2024 May 16;15:1399926. doi: 10.3389/fimmu.2024.1399926. eCollection 2024.
5
Metformin promotes cGAS/STING signaling pathway activation by blocking AKT phosphorylation in gastric cancer.二甲双胍通过阻断胃癌中的AKT磷酸化来促进cGAS/STING信号通路的激活。
Heliyon. 2023 Aug 6;9(8):e18954. doi: 10.1016/j.heliyon.2023.e18954. eCollection 2023 Aug.
6
cGAS-STING pathway in cancer biotherapy.cGAS-STING 通路在癌症生物治疗中的作用。
Mol Cancer. 2020 Sep 4;19(1):136. doi: 10.1186/s12943-020-01247-w.
7
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.cGAS-STING 信号通路在癌症免疫治疗策略中的新兴机制和意义。
Cancer Biol Med. 2024 Jan 3;21(1):45-64. doi: 10.20892/j.issn.2095-3941.2023.0440.
8
Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.传统的DNA损伤癌症疗法与新兴的cGAS-STING激活:关于免疫治疗潜力的综述与展望
Cancers (Basel). 2023 Aug 16;15(16):4127. doi: 10.3390/cancers15164127.
9
cGAS-STING pathway in oncogenesis and cancer therapeutics.cGAS-STING通路在肿瘤发生及癌症治疗中的作用
Oncotarget. 2020 Jul 28;11(30):2930-2955. doi: 10.18632/oncotarget.27673.
10
The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer.cGAS-STING 通路在胰腺癌治疗中的作用。
Front Immunol. 2021 Nov 9;12:781032. doi: 10.3389/fimmu.2021.781032. eCollection 2021.

引用本文的文献

1
The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis.cGAS-STING轴:从免疫防御到疾病发病机制的全面综述
Immunol Res. 2025 Jun 9;73(1):91. doi: 10.1007/s12026-025-09648-z.

本文引用的文献

1
An updated patent review of stimulator of interferon genes agonists (2021 - present).干扰素基因刺激剂的最新专利审查(2021 年至今)。
Expert Opin Ther Pat. 2024 May;34(5):297-313. doi: 10.1080/13543776.2024.2365409. Epub 2024 Jun 13.
2
A next-generation STING agonist MSA-2: From mechanism to application.一种新一代 STING 激动剂 MSA-2:从机制到应用。
J Control Release. 2024 Jul;371:273-287. doi: 10.1016/j.jconrel.2024.05.042. Epub 2024 Jun 1.
3
Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer.
IFN-γ 联合 STING 激动剂和 PD-1 免疫检查点阻断:胃癌的一种潜在免疫疗法。
Med Oncol. 2024 Apr 9;41(5):110. doi: 10.1007/s12032-024-02326-4.
4
Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways.通用型STING模拟物通过优先激活肿瘤控制信号通路增强抗肿瘤免疫力。
Nat Nanotechnol. 2024 Jun;19(6):856-866. doi: 10.1038/s41565-024-01624-2. Epub 2024 Mar 13.
5
cGAS-STING pathway agonists are promising vaccine adjuvants.cGAS-STING 通路激动剂是很有前途的疫苗佐剂。
Med Res Rev. 2024 Jul;44(4):1768-1799. doi: 10.1002/med.22016. Epub 2024 Feb 7.
6
Pembrolizumab plus chemotherapy for advanced gastric cancer.帕博利珠单抗联合化疗治疗晚期胃癌。
Lancet Oncol. 2024 Feb;25(2):e50. doi: 10.1016/S1470-2045(23)00573-9.
7
Exosome co-delivery of a STING agonist augments immunogenicity elicited by CVB3 VP1 vaccine via promoting antigen cross-presentation of CD8 DCs.外泌体共同递送STING激动剂通过促进CD8⁺ DCs的抗原交叉呈递增强柯萨奇病毒B3型VP1疫苗引发的免疫原性。
Int J Biol Macromol. 2024 Mar;261(Pt 1):129518. doi: 10.1016/j.ijbiomac.2024.129518. Epub 2024 Jan 18.
8
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
9
Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives.克服癌症免疫治疗中STING激动剂递送的挑战:策略与未来展望的全面综述
Mater Today Bio. 2023 Oct 21;23:100839. doi: 10.1016/j.mtbio.2023.100839. eCollection 2023 Dec.
10
Helicobacter pylori Treatment and Gastric Cancer Risk After Endoscopic Resection of Dysplasia: A Nationwide Cohort Study.幽门螺杆菌治疗与内镜下切除不典型增生后胃癌风险:一项全国性队列研究。
Gastroenterology. 2024 Feb;166(2):313-322.e3. doi: 10.1053/j.gastro.2023.10.013. Epub 2023 Oct 18.